|Bid||14.700 x 2600|
|Ask||14.750 x 600|
|Day's Range||14.675 - 15.050|
|52 Week Range||9.660 - 19.900|
|PE Ratio (TTM)||-35.31|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Q1 2017 Momenta Pharmaceuticals Inc Earnings Call
A launch delay has investors twiddling their thumbs.
Momenta Pharmaceuticals Inc. (MNTA) reported loss of 46 cents per share in the first quarter of 2017,which was narrower than the Zacks Consensus Estimate loss of $1.09. In fact, the company posted a loss of 35 cents in the year-ago quarter as well.